Rajesh Krishna

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Topics

Electronic Health Record

Liver Metastases

Top Venues

Clinical pharmacology and therapeutics

Journal of clinical pharmacology

Journal of pharmacokinetics and pharmacodynamics

Clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Mariam A Ahmed, Rajesh Krishna, Noha Rayad, Salwa Albusaysi, Amitava Mitra, Elizabeth Shang, Yuen Yi Hon, Bilal Abuasal, Rana Bakur Bakhaidar, Youssef M Roman, Indranil Bhattacharya, James C Cloyd, Munjal Patel, Reena V Kartha, Islam R Younis
Getting the Dose Right in Drug Development for Rare Diseases: Barriers and Enablers. Clinical pharmacology and therapeutics (2024)
Rajesh Krishna, Bernard Sebastien, Solange Corriol-Rohou, S Y Amy Cheung, Jing Liu, Satyendra Suryawanshi
Pediatric Rare Diseases Development in the Pharmaceutical Industry: An International Consortium for Innovation and Quality in Pharmaceutical Development, Clinical Pharmacology Leadership Group-Pediatrics Working Group, Rare Diseases Subteam Whitepaper Examining the Current Landscape and Recommendations for the Future. Clinical pharmacology and therapeutics (2024)
Amitava Mitra, Nessy Tania, Mariam A Ahmed, Noha Rayad, Rajesh Krishna, Salwa Albusaysi, Rana Bakur Bakhaidar, Elizabeth Shang, Maria Burian, Michelle Martin-Pozo, Islam R Younis
New Horizons of Model Informed Drug Development in Rare Diseases Drug Development. Clinical pharmacology and therapeutics (2024)
Amitava Mitra, Jong Bong Lee, Douglas Steinbach, Anasuya Hazra, Rajesh Krishna
Rare oncology therapeutics: review of clinical pharmacology package of drug approvals (2019-2023) by US FDA, best practices and recommendations. Journal of pharmacokinetics and pharmacodynamics (2023)
Xuyang Song, Robin Kate Kelley, Anis A Khan, Nathan Standifer, Diansong Zhou, KyoungSoo Lim, Rajesh Krishna, Lucy Liu, Kun Wang, Patricia McCoon, Alejandra Negro, Philip He, Megan Gibbs, John F Kurland, Ghassan K Abou-Alfa
Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients with Unresectable Hepatocellular Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Rajesh Krishna
Is QTc the Right Surrogate in Adequately Assessing the Risk for TdP for Development Compound Candidates? A Call to Investigate. Journal of clinical pharmacology 61 (10) (2021)
Rajesh Krishna
The Clinical Pharmacology Sections in Drug Package Inserts: Do We Need to Reexamine the Basis? Journal of clinical pharmacology 60 (6) (2020)
Michael G Dodds, Rajesh Krishna, Antonio Goncalves, Craig R Rayner
Model-informed drug repurposing: Viral kinetic modelling to prioritize rational drug combinations for COVID-19. British journal of clinical pharmacology 87 (9) (2020)
Rajesh Krishna
Enabling Warp Speed Using the Hypervelocity Innovation Model: A Blue Print for Drug Development in Pandemics. Clinical and translational science 13 (6) (2020)